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Heparin versus 0.9% sodium chloride intermittent flushing for 
the prevention of occlusion in long term central venous 
catheters in infants, children and adolescents: A systematic 
review*
*This paper is based a Cochrane Review published in the Cochrane Library 2015, 
issue 11, Art. No.: CD010996. DOI: 10.1002/14651858.CD010996.pub2 .  
Cochrane reviews are regularly updated as new evidence emerges and in 
response to feedback, and the Cochrane Database of Systematic Reviews should 
be consulted for the most recent version of the review. 
Abstract
Background
Around the world, guidelines and clinical practice for the prevention of 
complications associated with central venous catheters (CVC) vary greatly. To 
prevent occlusion, most institutions recommend the use of heparin when the 
CVC is not in use. However, there is debate regarding the need for heparin and 
evidence to suggest normal saline may be as effective. The use of heparin is not 
without risk, may be unnecessary and is also associated with increased costs.
Objectives
To assess the clinical effects (benefits and harms) of heparin versus normal 
saline to prevent occlusion in long-term central venous catheters in infants, 
children and adolescents.
Design
A Cochrane systematic review of randomised controlled trials was undertaken.
Data sources
The Cochrane Vascular Group Specialised Register (including MEDLINE, CINAHL, 
EMBASE and AMED) and the Cochrane Register of Studies were searched. Hand 
searching of relevant journals and reference lists of retrieved articles was also 
undertaken.
Review Methods
Data were extracted and appraisal undertaken.  We included studies that 
compared the efficacy of normal saline with heparin to prevent occlusion. We 
excluded temporary CVCs and peripherally inserted central catheters. Rate ratios 
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per 1000 catheter days were calculated for two outcomes, occlusion of the CVC,  
and CVC-associated blood stream infection.
Results
Three trials with a total of 245 participants were included in this review. The 
three trials directly compared the use of normal saline and heparin. However, 
between studies, all used different protocols with various concentrations of 
heparin and frequency of flushes. The quality of the evidence ranged from low to 
very low.  The estimated rate ratio for CVC occlusion per 1000 catheter days 
between the normal saline and heparin group was 0.75 (95% CI 0.10 to 5.51, two 
studies, 229 participants, very low quality evidence). The estimated rate ratio for 
CVC-associated blood stream infection was 1.48 (95% CI 0.24 to 9.37, two 
studies, 231 participants; low quality evidence). 
Conclusions
It remains unclear whether heparin is necessary for CVC maintenance. More 
well-designed studies are required to understand this relatively simple, but 
clinically important question. Ultimately, if this evidence were available, the 
development of evidenced-based clinical practice guidelines and consistency of 
practice would be facilitated.
What is already known about this topic?
 Central venous catheters maintenance practices vary around the world 
 Variations include the quantity of flush and lock solutions, the 
proportional volume of heparin lock solution, and the frequency of 
flushes and locks. 
 The use of heparin may be unnecessary, is costly and is not risk free 
What this paper adds?
 There was not enough evidence to determine which solution, heparin or 
normal saline, was superior to prevent occlusion in long-term central 
venous catheters in infants and children. 
 There is a need for healthcare organisations to consider undertaking 
further research in this area to contribute to the evidence base. 
 Nurses are ideally placed to contribute to such research and ultimately 
this would facilitate the development of evidence-based clinical practice 
guidelines and consistency of practice
Introduction 
Central venous catheters (CVCs) are commonly used in hospital-based care to 
enable the administration of medications and fluids, as well as for the collection 
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of blood specimens.  Long term CVCs are typically inserted when the 
administration of intravenous medication or nutritional support is required over 
a considerable time period. The use of long term CVCs for the management of 
complex or chronic medical conditions, such as cancer, in infants, children and 
adolescents,  has greatly improved the quality and safety of care provision. 
(Gonzalez et al., 2012)
Adverse events associated with CVCs, such as mechanical failure or central line 
associated-blood stream infection (CLABSI) may cause complications in up to 
46% of children (Athale et al., 2012). Mechanical failure is often attributed to 
catheter occlusion. Over time, it is common for a fibrin sheath to develop at the 
tip of the catheter. The fibrin sheath may prevent aspiration of blood from the 
catheter and cause resistance when infusing fluids. An intraluminal clot can also 
occur, which can totally occlude the catheter. Occlusion can result in the need for 
the catheter to be removed (and replaced), interrupting and delaying treatment 
of the underlying disease (Shah et al., 2007). 
To prevent occlusion, it is common to regularly flush the CVC with 0.9% sodium 
chloride, and to use a heparin lock when the CVC is not in use. However, there is 
debate regarding the effectiveness of heparin to prevent occlusion over long time 
periods, given its short half-life (Young, 2008). The evidence to support the use 
of heparin to prevent occlusion in adult CVCs is inconclusive and there is 
growing evidence to support the use of 0.9% sodium chloride (normal saline) to 
lock CVCs, particularly in the paediatric population (Bertoglio et al., 2012, Lee 
and Johnston, 2005).  Normal saline, when used with pulsatile (push-pause 
rather than continuous) flushing techniques and a positive pressure lock or 
positive displacement device, may be as effective in preventing thrombus 
formation in catheters - eliminating the need for heparin to be used.
Catheter maintenance practices vary among institutions because of the lack of 
evidence regarding best practice to prevent occlusion of CVCs (Lee and Johnston, 
2005, Conway et al., 2014).Variations include the quantity of flush and lock 
solutions, the proportional volume of heparin lock solution, and the frequency of 
flushes and locks. The use of heparin is not risk free and in certain instances may 
actually cause harm, including infection (Shanks et al., 2005) and heparin-
induced thrombocytopenia (HIT)  (Barclay et al., 2012). Additionally, treatments 
for diseases such as cancer involve the use of medications that can affect 
coagulation. For these reasons the use of heparin to prevent CVC occlusion 
should be judicious and evidence-based. While the risks of adverse effects from 
the use of heparin may be regarded as less than the potential occlusion of a 
catheter and subsequent replacement, it is important to ensure interventions are 
based on evidence.
In the adult population, there have been several trials (Goossens et al., 2013, 
Schallom et al., 2012) a systematic review (Mitchell et al., 2009), and a Cochrane 
Review of the use of heparin versus normal saline to prevent occlusions in CVCs 
(Lopez-Briz et al., 2014).  As evidence from adult studies is not directly 
transferable to paediatrics, a systematic review focused on infants and children 
is required. A review published in 2014 that did relate specifically to paediatrics, 
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(Conway et al., 2014) did not identify all relevant studies and made 
recommendations based on the current practice of several institutions. These 
recommendations were not evidence-based, and are contrary to the practice of 
many other institutions. Therefore, it is important to systematically appraise the 
evidence for the use of heparin compared with normal saline to prevent 
occlusion of central venous catheters.
Aims 
To compare the clinical effects (benefits and harms) of heparin versus normal 
saline to prevent occlusion in long-term central venous catheters in infants, 
children and adolescents.
Methods 
Criteria for inclusion in this review 
We undertook a Cochrane systematic review (Bradford et al., 2015). We included 
all randomised controlled trials (RCTs) that compared the efficacy of heparin 
with normal saline for the prevention of occlusion of CVCs. The participants were 
infants, children and adolescents aged 0 to 18 years of age, who had a CVC 
(tunnelled catheter or totally implanted catheter), inserted for long-term venous 
access. Because midline catheters are not placed in the same position as a CVC 
(superior or inferior vena cava), and PICC have narrow lumens that require 
specific care, they were excluded. Where studies had a mixed population that 
included infants, children and adults, we included data from infants and children 
only. If information was not presented in the article, we contacted the study 
authors to attempt to obtain age-stratified results. 
The interventions were the intermittent (any time frequency) flushing of heparin 
(any dose or concentration) compared with intermittent flushing with normal 
saline (alone, or in combination with pulsatile flushing techniques, positive 
displacement devices or positive pressure lock) delivered with the intention to 
prevent occlusion of the CVC.
The outcomes included: 
 Occlusion of the CVC, determined by the inability to infuse fluids through 
the catheter.
 CVC-associated blood stream infection or colonisation of the catheter.
 Duration in days of catheter placement.
 Inability to withdraw blood from the CVC.
 Any use of urokinase or recombinant tissue plasminogen such as 
alteplase.
 Incidence of removal/re-insertion of the catheter.
 Other CVC-related complication (e.g. dislocation of CVCs, thrombosis, 
tunnel or site infection, allergic reaction, haemorrhage, heparin-induced 
thrombocytopaenia, elevated hepatic enzymes.
Identification of studies
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The Cochrane Vascular Trials Search Co-ordinator (TSC) searched the 
Specialised Register and the Cochrane Register of Studies (CRS) 
http://www.metaxis.com/CRSWeb/Index.asp (2015, Issue 3). The Specialised 
Register is maintained by the TSC and is constructed from weekly electronic 
searches of MEDLINE, EMBASE, CINAHL, AMED, and through hand-searching 
relevant journals. Trial databases were searched by the TSC in April 2015 for 
details of ongoing and unpublished studies using the terms heparin and sodium 
and (catheter or cannula or CVC or PICC).  No restriction was placed on language.
Study screening
Two review authors (NB, RE) independently reviewed all titles and abstracts of 
retrieved articles to assess eligibility against inclusion criteria. Discrepancies 
were resolved by consensus. 
Data extraction
Two review authors (NB, RC) extracted the data independently using the 
Cochrane Vascular Group forms for dichotomous and continuous data. Data were 
collected regarding the: lead author and year of study; country where the study 
was undertaken; participant inclusion criteria; participant age and gender; study 
design; description of interventions; setting of study; number of participants in 
each arm; attrition or losses to follow-up; catheter days at risk; outcome 
measures. We resolved any disagreement regarding data extraction by 
discussion between all review authors (NB, RE, RC).
Study quality assessment
We assessed bias within studies using the tool described in the Cochrane 
Handbook for Systematic Reviews of Interventions (Higgins and Green, 2011)
reporting the following domains: sequence generation; allocation concealment; 
blinding; incomplete data; selective outcome reporting, and other biases.  This 
led to an overall assessment of bias of each of the included studies. Two review 
authors (NB, RC) independently undertook the risk of bias assessment. 
Disagreement regarding the assessment of bias was resolved by discussion 
between review authors (NB, RC).
Data analysis
As dichotomous outcomes such as CVC occlusion or CVC-associated blood stream 
infection could occur more than once for individual participants, we calculated 
count data per time at risk of outcome (per 1000 catheter days) and reported 
rate ratios with 95% confidence intervals (CI). Using section 9.4.8 of the 
Cochrane Handbook for Systematic Reviews of Interventions (Higgins and Green, 
2011) we also calculated the formula for the log of the standard error for each 
rate ratio. We pooled data statistically using meta-analysis Review Manager 
software (Cochrane Collaboration, 2011). Where substantial heterogeneity 
existed, we pooled data using the random-effects model. The decision to carry 
out meta-analysis was made after discussion with the Cochrane biostatistician 
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and with consensus from all authors. Where it was not appropriate to combine 
results, we presented a narrative review descriptively summarising the results
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Table 1 Characteristics of included studies
Study, country, setting, participants  
and Catheter days at risk
Description of intervention, 
controls
Outcomes Notes
Potential confounding of results due to 
outcomes being attributable to positive 
pressure cap or frequency between flushes 
rather than the flushing solution used
 Random sequence generation
 Allocation concealment
 Blinding of participants and personnel
 Blinding of outcomes assessment
 Complete data (attrition)
? Selective reporting
Cesaro et al (2009)
Country: Italy
Clinical setting: single tertiary 
referral centre
Participants: 203 paediatric (age 0-17 
years) haematology or oncology 
patient with tunnelled Brioviac CVC 
inserted for chemotherapy.
Catheter days at risk: 75,249 
Experimental treatment group:
flushing with normal saline at least 
weekly via a positive pressure cap
Standard treatment group: flushing 
with 3 mL of normal saline with 200 
units heparin twice weekly via a 
standard CVC cap
 Incidence of CVC 
complications: occlusion, 
dislocation of CVC, CVC-
related infection, exit 
site infection, 
thrombosis
 CVC survival (weeks)
 Organisms isolated from 
blood cultures
 Other bias
Subset of paediatric data (unpublished) was 
obtained to assess outcomes for children 
only: 26 out of 28 children contributed data. 
Not all variables available, there may be 
some systematic differences in the 
characteristics of children in the subset of 
data, the study was not powered to analyse 
this subset of data separately
 Random sequence generation
 Allocation concealment
 Blinding of participants and personnel
 Blinding of outcomes assessment
? Complete data (attrition)
? Selective reporting
 Other bias
Goossens et al (2013)
Country: Belgium
Clinical setting: single tertiary 
referral centre
Participants:  802 individuals (0-71 
years old) with an oncology or 
haematology condition, who had a 
totally implantable intravenous 
catheter inserted. A subset of 
unpublished data was obtained from 
the investigators for 28 (3.5%) 
participants, aged one to 18 years of 
age
Catheter days at risk: 115,991 (The 
assumption was made that the mean 
catheter days was equivalent in the 
paediatric population)
Experimental treatment group: 
pulsatile flushing with 10 mL of 
normal saline and then locking with 
positive pressure
Standard treatment group: pulsatile 
flushing with 10 mL of normal saline, 
followed by 3 mL heparin (100 
units/mL) and locking with positive 
pressure
 Rate of inability to 
aspirate blood while 
injection was easy 
(assessed at every 
access)
 Incidence of CVC-
associated blood stream 
infection
 Incidence of functional 
problems associated 
with CVC
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Older study, not reported using contemporary 
standards. Potential for confounding of results 
due to outcomes being attributable to frequency 
between flushes rather than solution used. No 
information available for first cross-over period 
results
? Random sequence generation
? Allocation concealment
 Blinding of participants and personnel
 Blinding of outcomes assessment
 Complete data (attrition)
 Selective reporting
Smith et al (1991)
Country: Canada
Clinical Setting: single tertiary 
referral centre
Participants 14 participants (21 
months-20 years of age) with a 
tunnelled Broviac CVC
As a cross-over design, the same 
participants were in both the 
experimental treatment group and the 
standard treatment group
Catheter days at risk: 3029 
Experimental treatment group: once 
per week flush with 9 mL normal 
saline
Standard treatment group: twice 
daily flushes with 5 mL heparinised 
normal saline (10 units/mL heparin)
 Thrombosis formation at 
baseline, cross over 
point (14 weeks) and 
end of study (28 weeks) 
as measured by 
echocardiogram or 
inability to infuse or 
withdraw from CVC 
(occlusion)
 Incidence of CVC 
mechanical issues (leak, 
migration)
 Incidence of CVC-
associated infection
 Other bias
 - Low risk of bias
? – Unclear risk of bias
- Risk of bias
CVC – Central Venous Catheter
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Results 
Search Results
Study screening of 137 citations identified 10 studies that were potentially 
relevant and the full text were reviewed.  We contacted three individual study 
authors for further study details and were able to find further information for 
two studies (Goossens et al., 2013, Smith et al., 1991).  Of the 10 studies, three 
met the inclusion criteria (Cesaro et al., 2009, Goossens et al., 2013, Smith et al., 
1991) and were included in this review.  Details of data extraction are 
summarised in Table 1. A flow chart detailing the identification of studies can be 
found in Figure 1. 
The studies undertaken by Cesaro et al., (2009) and Goossens et al., (2013) were 
of medium duration (25 and 23 months respectively) and included follow-up 
periods of 14 and six months respectively. The Smith et al., (1991) study was a 
cross-over study of two, three-and-a-half month time periods (total duration 
seven months) and did not include a follow-up period. We were not able to 
ascertain if this study was analysed as paired data or not, and no information 
was available regarding the first cross-over period, therefore this study was not 
pooled with the others for meta-analysis. All studies had obtained ethical 
approval from their relevant institutions.
Population
The three included trials involved a total of 245 participants, with the majority of 
participants (203) coming from Cesaro et al., (2009).  From the other two 
studies, Goossens et al., (2013) contributed 28 participants, and Smith et al., 
(1991) contributed 14.  All participants had a long-term central venous catheter 
placed, and were undergoing treatment for haematology or oncology conditions. 
Participants in Cesaro et al., (2009) and Smith et al., (1991) had Broviac 
tunnelled CVCs inserted, whereas all participants in Goossens et al., (2013) had 
totally inserted catheters (ports) placed. All studies were undertaken in 
developed nations in t rtiary referral centres. Both Cesaro et al., (2009) and 
Goossens et al., (2013) undertook power size calculations to obtain sample sizes, 
however it is important to note that children comprised only 3.5% of Goossens 
et al., (2013) study population, thus this study was not powered to analyse the 
results of children separately.
Interventions
Participants in all three included studies received standard care except where 
stated as follows. All studies involved an experimental arm where normal saline 
solution was used in place of standard solution (heparinised saline) when the 
CVC was not being used. As well as changing the type of solution used to flush the 
CVC, Smith et al., (1991) increased the time between flushes in the intervention 
arm from twice daily to weekly. Similarly, Cesaro et al., (2009) increased the 
duration between flushes in the intervention arm compared to standard care 
from twice per week to weekly. Cesaro et al., (2009) also introduced a positive 
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pressure cap into the intervention arm. These changes confound the 
interventions so it is not possible to associate outcomes with the use of the 
solution alone. Goossens et al., (2013) was the only study included in this review 
where the only difference between the intervention and standard arm was the 
use of normal saline (experimental) or heparin (standard) solution to flush the 
CVC.  
Control
In all studies, participants randomised to the standard arm received various 
concentrations of heparinised saline to flush their CVC. Participants in Smith et 
al., (1991) study received 5 mL of 10 units/mL heparinised saline (i.e. 50 units of 
heparin) twice daily. Participants in Cesaro et al., (2009) study received 3 mL of 
200 units/mL heparinised saline (i.e. 600 units of heparin) twice weekly. In 
Goossens et al., (2013) study, participants in the standard arm received 3 mL of 
100 units/mL heparin (i.e. 300 units of heparin) under positive pressure at least 
every eight weeks when the CVC was not in use.
Outcomes
The primary outcome of interest, occlusion of CVC, was measured in all three 
studies. We were able to pool data related to occlusion and incidence of CVC –
associated blood stream infection for two studies (Cesaro et al., 2009, Goossens 
et al., 2013). All studies reported the catheter-days participants were at risk of 
experiencing an outcome.
Methodological quality of studies
There was low risk of selection bias in the Cesaro et al., (2009) and Goossens et 
al., (2013) studies; these investigators reported using computerised random 
sequencing and concealing allocation until participants had been recruited and 
provided consent. Smith et al., (1991) study did not provide randomisation 
details. None of the three included studies blinded investigators, clinicians or 
participants regarding to which arm the participant had been allocated. All 
outcomes were objectively measured, but in all three studies there is the 
possibility clinicians may have modified their technique depending on the arm to 
which the participant had been allocated. All studies were therefore assessed as 
a high risk of both performance and detection bias. All three studies reported full 
results for primary and secondary outcomes for all participants. There were no 
study protocols available, therefore reporting bias for all studies is unclear. 
Smith et al., (1991) reported data in a basic format with no results from 
statistical tests. 
In both the Cesaro et al., (2009) and Smith et al., (1991) studies, there is a high 
concern for confounding of results. Both these studies altered the frequency 
between flushes for the experimental arm as well as the experimental solution. 
Additionally in Cesaro et al., (2009) the experimental arm included the use of a 
positive pressure cap. It is not possible therefore to attribute the outcome to the 
use of the solution alone, the outcome could plausibly also be attributed to the 
frequency of flushes or the use of a positive pressure cap. It may therefore be 
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more appropriate to view the intervention as a component of a bundle of care. 
Further bias may exist in the subset of unpublished data of paediatric 
participants provided by Goossens et al., (2013) . As a cross over study there may 
have been a carry-over effect of the intervention from one arm to the other in 
Smith et al., (1991). It is not clear if the study authors considered this. These 
other potential sources of bias across all three studies are substantial and reduce 
confidence in the results.
Effects of interventions 
CVC occlusion 
CVC occlusion was reported in all three included trials (243 participants; 
Goossens et al., (2013) provided data for 26 of 28 participants for CVC 
occlusion). In both Smith et al., (1991) and Cesaro et al., (2009) there were more 
CVC occlusions in the experimental (normal saline) arm. Rates were calculated 
for each study based upon 1000 catheter days and are presented as rate ratios of 
saline versus heparin (see Table 2). We pooled the results from the (Cesaro et al., 
2009) and (Goossens et al., 2013) using random effects because of the clinical 
heterogeneity between studies (e.g. difference in frequency of flushing, 
implanted catheters and tunnelled catheters, use of positive pressure cap). The 
analysis suggested there was no statistical difference in the outcome of CVC 
occlusion between flushing with heparin or normal saline (rate ratio 0.75, 95% 
CI 0.10 to 5.51; participants = 229; studies = 2; Z = 0.29, P = 0.78). However the 
heterogeneity between studies indicates this result may be due to differences 
between the studies (See Figure 2). The results were imprecise and we graded 
this evidence as very low quality
Table 2. Rate ratio of outcome per 1000 catheter days – saline versus heparin
Smith et al., (1991)
Cesaro et al., 
(2009)
Goossens et al., 
(2013)
Outcome per 1000
catheter days
Rate 
ratio# 
Variance* Rate 
ratio#
Variance* Rate 
ratio#
Variance*
CVC occlusion 2.0 1.22 1.95 0.19 0.25 0.54
CVC-associated blood 
stream infection rate 
2.0 1.22 2.58 0.39 0.31 1.55
Inability to withdraw 
blood
Not 
reported
N/A Not 
reported
N/A 0.32 0.47
CVC dislodgement 0.2 1.55 0.87 0.32 Not 
reported
N/A
CVC site infection 7.0 1.51 0.68 0.41 Not 
reported
N/A
CVC-related thrombosis 1.0 1.41 1.0 1.41 Not 
reported
N/A
CVC- Central venous Catheter
# - incidence in saline group/incidence in heparin group
*- variance calculated as the standard error of the log rate ratio
N/A – not applicable
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CVC-associated blood stream infection or colonisation 
Incidence of CVC-associated blood stream infection was reported in all three 
included trials (245 participants). Rates were calculated as above (see table 2). 
There were more CVC-associated blood stream infections in the experimental 
(normal saline) arm in both Cesaro et al., (2009) and Smith et al., (1991) studies. 
We pooled the results of Cesaro et al., (2009) and Goossens et al., (2013) and 
found there was no significant association between the use of saline to flush CVC 
and the incidence of CVC-associated blood stream infection (rate ratio 1.48, 95% 
CI 0.24 to 9.37; participants = 231; studies = 2; Z = 0.42, P = 0.67). We graded this 
evidence as low quality as results were imprecise  (See Figure 3). 
Duration of CVC placement (days)
After a median follow-up of 360 days, Cesaro et al., (2009) reported that CVC 
survival was similar between the two study arms (203 participants): saline = 
77% (95% CI 66% to 84%), heparin = 69% (95% CI 53% to 80%). Duration of 
CVC placement was not reported in the other two studies. 
Inability to withdraw blood from the CVC
Goossens et al., (2013) reported on the inability to withdraw blood from the CVC 
(26 participants). Compared to normal saline group, there was a decreased 
inability to withdraw blood from the CVC in the heparin group, rate ratio 0.32 
(95% CI 0.14 to 0.88). This outcome was not reported in the other studies. 
Any use of urokinase or recombinant tissue plasminogen
Urokinase was used in 116 of 124 (94%) episodes of CVC occlusion in Cesaro et 
al., (2009) study of 203 patients, and patency was restored in 107 out of 116 
(92%). Of note, 83 CVCs occluded in the normal saline group and 41 in the 
heparin group. Five of the CVCs were occluded in only one lumen and so were 
left in situ while the remaining four were unable to have patency restored in 
either lumen and were prematurely removed. There was no information 
regarding this outcome available in the other studies.
Incidence of removal/re-insertion of the catheter
Cesaro et al., (2009) reported premature removal of a CVC was required in 44 
(22%) participants. Premature removal was comparable between the two study 
arms, and was generally indicated because of dislocation of the catheter or 
infection, rather than CVC occlusion. There was no information regarding this 
outcome from the other studies.
Other CVC-related complications
Dislodgment of the CVC occurred in 38/203 (19%) of the total study population 
in Cesaro et al., (2009) There were no statistical differences between study arms; 
rate ratio 0.87 (95% CI 0.46 to 1.63). In Smith et al., (1991) dislodgement 
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occurred in 2/14 (14%) of the study population. There was no statistically 
significant difference between study arms; rate ratio 0.2 (95% CI 0.01 to 4.81). 
There was no information regarding this outcome available from Goossens et al., 
(2013). 
CVC site infection was reported in 24/203 (12%) in Cesaro et al., (2009) with no 
statistically significant differences between study arms; rate ratio 0.68 (95% CI 
0.30 to 1.52). In Smith et al., (1991) CVC site infection was reported in 6/28 
(21%) of the study population, again there was no difference between study 
arms and the results were imprecise; rate ratio 7.0 (95% CI 0.37 to 132.4).
CVC-related thrombosis was reported in 2/203 (1%) of the study population in 
Cesaro et al., (2009) with no differences between study arms; rate ratio 1.0 (95% 
CI 0.06 to 15.86). In Smith et al., (1991), CVC-related thrombosis was reported in 
2/14 (14%) of the population, again there was no difference between study arms 
and results were imprecise; rate ratio 1.0 (95% CI 0.06 to 15.86).
There were no data available from Goossens et al., (2013) regarding other CVC 
complications in the paediatric population of 28 patients.
Discussion 
This systematic review compared the use of heparin locks (standard care) with 
experimental use of normal saline locks. The quantity of the evidence was small; 
we were only able to include three studies and the results were inconsistent. We 
found that there is insufficient data to determine the effects of intermittent 
flushing of normal saline versus heparin to prevent CVC occlusion or CVC-
associated blood stream infection in infants and children. The use of a positive 
pressure cap in Cesaro et al., (2009) may have biased the results of this study 
regarding the outcome of CVC-associated blood stream infection; there is 
evidence of an association between the use of a positive pressure cap and CVC-
associated blood stream infection in other studies (Jacobs et al., 2004, Jarvis et 
al., 2009, Marschall et al., 2014).
The trials included in the review directly compared the use of normal saline and 
heparin in long-term central venous catheters in children in community and 
acute settings, and we were able to undertake two meta-analyses. All studies 
included participants representative of those usually found in the clinical setting. 
However, between studies, all used different protocols for the standard and 
experimental arms with different concentrations of heparin and different 
frequency of flushes reported. Additionally, within studies, Cesaro et al., (2009)
and Smith et al., (1991) changed not only the solution being used, but also the 
frequency of flushes. Any difference seen could therefore be plausibly attributed 
to either the solution or the frequency of flushes; changing the frequency of 
flushes may actually confound the results towards the null hypothesis.
The three included studies employed a pragmatic approach to assess the 
effectiveness of saline in routine care. While this approach is desirable to inform 
policy and routine practice, greater emphasis is required to minimise bias and 
confounding in the study design to ensure generalisibility. As there are concerns 
with the internal validity of all three studies, the generalisibility (external 
validity) of results from the studies included in the review is poor.
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The overall quality of the evidence was assessed as very low to low using the 
GRADE assessment tool; there was a high risk of performance and detection bias 
in all studies as well as a high risk of other bias related to differences in 
frequency of flushes between heparin and saline groups in Cesaro et al., (2009)
and Smith et al., (1991). A high risk of other bias is also assumed for the subset of 
unpublished paediatric data provided for Goossens et al., (2013). In addition we 
identified heterogeneity, imprecision and inconsistency of the effect estimates. 
Consequently, the significance of the results of these meta-analyses should be 
interpreted with caution. Further research is likely to improve the confidence in 
the estimate of these effects if undertaken with greater attention to 
methodology.
The study undertaken by Smith et al., (1991) in particular is subject to high 
levels of uncertainty regarding its precision. This study was undertaken many 
years ago and is reported with minimal detail. Following this study, the 
institution where the study was conducted changed their practice, replacing 
heparin with normal saline locks. Recent communication with this institution 
confirmed that the facility continues to routinely use normal saline locks for long 
term CVCs in children over 12 months of age, providing strong support of the 
study's findings. Therefore despite the bias evident in this study, it is important 
to consider the clinical implications of the experience of the efficacy of normal 
saline locks in long term CVCs over two decades.
Comparison to other evidence
A recent systematic review (Conway et al., 2014) concurred with our findings 
that there is insufficient evidence to support the use of normal saline to prevent 
CVC occlusion. This review included studies related to the adult population and 
also peripherally inserted CVCs.  Conway et al., (2014) concluded with 
recommendations for daily flushing with heparin based on the practices of 
selected facilities. However, there is insufficient evidence to make this 
recommendation and this recommendation may lead to higher amounts of 
heparin being used than is necessary, introducing avoidable costs and risks 
associated with the use of heparin in this patient group. 
There are numerous observational studies that investigate this issue (Fratino et 
al., 2005). Many of these studies support the use of normal saline for routine 
flushing of long term CVCs (Abate et al., 2014, J Kelly, 2008) and institutions 
report the practice of using normal saline in their clinical practice guidelines 
(Nelson et al., 2008). Despite the literature suggesting that heparin may not be 
required to maintain patency of CVCs, more RCTs are required to determine the 
ideal flush solution, concentration, and the frequency of flushes (Baskin et al., 
2009). Without strong evidence to support the use normal saline, debate will 
continue and inconsistencies in practice will prevail. In an area where patients 
are already vulnerable as a result of their disease state, there should be greater 
understanding of this relatively simple question and clinical practice should be 
standardised.
Implications for education practice and research
Page 16 of 20
Ac
ce
pte
d M
an
us
cri
pt
18
There is insufficient evidence to determine the effects of intermittent flushing of 
heparin versus normal saline to prevent occlusion in long-term central venous 
catheters in infants and children. It remains unclear whether heparin is 
necessary to prevent occlusion or CVC-associated blood stream infection. 
Controversy between institutions around the world regarding the appropriate 
care and maintenance of these devices remains. Given the results of this review, 
there is a need for healthcare organisations to consider undertaking further 
research in this area to contribute to the evidence base. Ultimately this would 
facilitate the development of evidence-based clinical practice guidelines and 
consistency of practice. Nurses are ideally placed to contribute to this research. 
Careful attention to study design is required, including blinding and proper 
sample size calculations to detect clinically meaningful differences, and ensuring 
only one aspect of the intervention is changed in the experimental arm (flushing 
frequency, concentration of heparin or use of normal saline). Cost analysis would 
be a useful addition to future studies. Consistency of outcome reporting would 
aid interpretation of results. Such studies would generate evidence and ensure 
results could be appraised and generalised to address the current gaps in 
knowledge.  
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Figures
Figure 1: Flow chart of search strategy
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Figure 2: Forest plot comparison: normal saline versus heparin flush, outcome 
CVC occlusion rate per 1000 catheter days
Figure 3: Forest plot comparison: normal saline versus heparin flush, outcome 
CVC associated blood stream infection rate per 1000 catheter 
days
CVC – Central Venous Catheter
SE – Standard Error
IV – Inverse Variance
CI- Confidence Interval
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